Skip to main content

Male midlife hormones · for men and their partners

Andropause, the honest primer

Age-related testosterone decline in men, in plain language. What the guidelines actually say, which symptoms cluster, what to test first, what the treatment menu looks like, and the mimics worth ruling out before you touch a hormone.

Seven areas below, each with what the guidelines say, what the trade-offs look like, and the questions worth bringing in. Skim, then jump.

This page is education, not advice.

Nila is menopause-first and this is our primer on the male side of midlife. Nothing here is a recommendation to start, stop or change a medication. Use it to know what exists and to bring better questions to your doctor or specialist.

Strong evidence

Multiple solid human trials and guideline support. Recognised straight away by an endocrinologist or a men's-health-literate doctor.

Promising

Good early human data and in real-world use, but the evidence base is still maturing. Worth raising; worth a real conversation.

Traditional use

Long use with modest modern data, or newer options still earning their place. Useful to know exists.

A menu, not a prescription.

Start here

What are you actually trying to sort out?

Tap the area that fits the loudest symptom. We'll jump you to what's on the menu for it — the full primer is right underneath.

Further reading

The evidence this page draws from.

A short, deliberately mixed list: the big trial that keeps everyone cautious, the guidelines that shape what doctors do, and one clinician-written book that argues the condition is under-recognized. Read them together, not one in isolation.

The TTrials, NEJM 2016

Effects of Testosterone Treatment in Older Men

The landmark NIH-supported trial: 790 men aged 65+ with low testosterone. Raising levels for one year improved sexual function and mood a little, but did not improve vitality or walking distance. Bone density and haemoglobin improved; cardiovascular signals were mixed. This is the study that keeps the conversation cautious.

Read

American College of Physicians, 2020

Testosterone Treatment in Adult Men With Age-Related Low Testosterone

Clinical guideline advising that testosterone should only be considered for men with clearly low testosterone and sexual dysfunction, and that the decision should include a frank discussion of limited benefits and possible cardiovascular risk.

Read

European Academy of Andrology, 2020

Investigation, Treatment and Monitoring of Functional Hypogonadism in Males

A practical guideline on how to distinguish true testosterone deficiency from the reversible forms that look like it: obesity, sleep apnoea, alcohol, depression, medications, and chronic illness. Useful for reading before a doctor's appointment.

Read

Italian Society of Andrology and Sexual Medicine / Italian Society of Endocrinology, 2022

Adult- and Late-Onset Male Hypogonadism

A comprehensive guideline on diagnosis, comorbidities, and treatment choices in adult-onset hypogonadism, with clear warnings against treating men who do not have a persistent low testosterone level.

Read

Professor Malcolm Carruthers, 2nd ed. 2020

Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment

A clinician-written reference that argues for recognising androgen deficiency as a real and treatable condition. Worth reading alongside the guidelines above, because Carruthers is more symptom-led than the trial literature. He also runs a men's health clinic, so treat it as one perspective, not the final word.

Read